Schwartz PE - Search Results

1

Superior in vitro and in vivo activity of trastuzumab-emtansine (T-DM1) in comparison to trastuzumab, pertuzumab and their combination in epithelial ovarian carcinoma with high HER2/neu expression.

Menderes G, Bonazzoli E, Bellone S, Altwerger G, Black JD, Dugan K, Pettinella F, Masserdotti A, Riccio F, Bianchi A, Zammataro L, de Haydu C, Buza N, Hui P, Wong S, Huang GS, Litkouhi B, Ratner E, Silasi DA, Azodi M, Schwartz PE, Santin AD. Menderes G, et al. Among authors: schwartz pe. Gynecol Oncol. 2017 Oct;147(1):145-152. doi: 10.1016/j.ygyno.2017.07.009. Epub 2017 Jul 10. Gynecol Oncol. 2017. PMID: 28705408 Free PMC article.

2

Ovarian cancer staging: does it require a gynecologic oncologist?

Mayer AR, Chambers SK, Graves E, Holm C, Tseng PC, Nelson BE, Schwartz PE. Mayer AR, et al. Among authors: schwartz pe. Gynecol Oncol. 1992 Nov;47(2):223-7. doi: 10.1016/0090-8258(92)90110-5. Gynecol Oncol. 1992. PMID: 1468701 Free article.

3

Correlation between measured creatinine clearance and calculated creatinine clearance in ovarian cancer patients.

Chambers JT, Chambers SK, Schwartz PE. Chambers JT, et al. Among authors: schwartz pe. Gynecol Oncol. 1990 Jan;36(1):66-8. doi: 10.1016/0090-8258(90)90110-7. Gynecol Oncol. 1990. PMID: 2295454

4

Neoadjuvant chemotherapy in stage X ovarian carcinoma.

Chambers JT, Chambers SK, Voynick IM, Schwartz PE. Chambers JT, et al. Among authors: schwartz pe. Gynecol Oncol. 1990 Jun;37(3):327-31. doi: 10.1016/0090-8258(90)90361-n. Gynecol Oncol. 1990. PMID: 2351315

5

Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity.

Chambers SK, Flynn SD, Del Prete SA, Chambers JT, Schwartz PE. Chambers SK, et al. Among authors: schwartz pe. Gynecol Oncol. 1989 Mar;32(3):303-9. doi: 10.1016/0090-8258(89)90629-x. Gynecol Oncol. 1989. PMID: 2465939

6

A study of the monoclonal antibody OC 125 to diagnose malignant ovarian tumors.

Li XG, Chen DX, Schwartz PE, Yang Z. Li XG, et al. Among authors: schwartz pe. Gynecol Oncol. 1989 Mar;32(3):327-30. doi: 10.1016/0090-8258(89)90634-3. Gynecol Oncol. 1989. PMID: 2920953

7

Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. II. Initial serial studies.

Wang YX, Schwartz PE, Chambers JT, Cole LA. Wang YX, et al. Among authors: schwartz pe. Gynecol Oncol. 1988 Sep;31(1):91-102. doi: 10.1016/0090-8258(88)90274-0. Gynecol Oncol. 1988. PMID: 3410359

8

A phase II study of etoposide, cisplatin, and doxorubicin chemotherapy in mixed müllerian tumors (MMT) of the uterus.

Resnik E, Chambers SK, Carcangiu ML, Kohorn EI, Schwartz PE, Chambers JT. Resnik E, et al. Among authors: schwartz pe. Gynecol Oncol. 1995 Mar;56(3):370-5. doi: 10.1006/gyno.1995.1065. Gynecol Oncol. 1995. PMID: 7705670 Free article. Clinical Trial.

9

Effect of combination chemotherapy with cisplatin and cyclophosphamide on human immunodeficiency virus type-1 surrogate markers in a patient with advanced epithelial ovarian cancer.

Fishman DA, Viscarello RR, Cass I, Schwartz PE. Fishman DA, et al. Among authors: schwartz pe. Gynecol Oncol. 1995 Apr;57(1):105-8. doi: 10.1006/gyno.1995.1105. Gynecol Oncol. 1995. PMID: 7705691 Free article.

10

Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC).

Price FV, Chambers SK, Carcangiu ML, Kohorn EI, Schwartz PE, Chambers JT. Price FV, et al. Among authors: schwartz pe. Gynecol Oncol. 1993 Dec;51(3):383-9. doi: 10.1006/gyno.1993.1308. Gynecol Oncol. 1993. PMID: 8112650 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters